Eczema natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 13: Line 13:
*[[Eczema]] has regarded as a [[medical]] condition with a natural history that occurs consistently.  
*[[Eczema]] has regarded as a [[medical]] condition with a natural history that occurs consistently.  
*It is characterized as a [[disease]] with an early onset, mostly during the [[childhood]] period, and remits during the [[adolescence]] period. <ref name="pmidhttps://doi.org/10.1016/j.jaci.2017.09.044"> {{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1016/j.jaci.2017.09.044 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>
*It is characterized as a [[disease]] with an early onset, mostly during the [[childhood]] period, and remits during the [[adolescence]] period. <ref name="pmidhttps://doi.org/10.1016/j.jaci.2017.09.044"> {{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1016/j.jaci.2017.09.044 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>
=== Comorbidities ===
* [[Individuals]] suffering from [[eczema]] often have comorbidities like [[asthma]] <ref name="pmidhttps://doi.org/10.4168/aair.2011.3.2.67">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.4168/aair.2011.3.2.67 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>, [[allergic rhinitis]] <ref name="pmidhttps://doi.org/10.1016/S0140-6736(81)92459-4">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1016/S0140-6736(81)92459-4 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>, [[contact dermatitis]] <ref name="pmidhttps://doi.org/10.1111/j.1600-0536.1990.tb01595.x">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1111/j.1600-0536.1990.tb01595.x | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>, and [[food allergy]] <ref name="pmidhttps://doi.org/10.1016/S0140-6736(81)92459-4">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1016/S0140-6736(81)92459-4 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>.


=== Complications ===
=== Complications ===

Revision as of 15:51, 10 June 2022

Eczema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eczema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Social Impact

Future or Investigational Therapies

Case Studies

Case #1

Eczema On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eczema

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eczema

CDC on Eczema

Eczema in the news

Blogs on Eczema

Directions to Hospitals Treating Eczema

Risk calculators and risk factors for Eczema

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.


Overview

Eczema has regarded as a medical condition with a natural history that occurs consistently. It is characterized as a disease with an early onset, mostly during the childhood period, and remits during the adolescence period. [1] If eczema is left untreated, it can lead to viral, bacterial and fungal infections. Psychological problems could also arise brought about by constant itching.

Eczema Natural History, Complications, and Prognosis

Natural History

  • Eczema has regarded as a medical condition with a natural history that occurs consistently.
  • It is characterized as a disease with an early onset, mostly during the childhood period, and remits during the adolescence period. [1]

Comorbidities

Complications


 Table 1. Complications of Eczema.
Complications Description
Bacterial Infections Staphylococcus aureus[5][6] and Methicillin-resistant S. aureus colonization. [7] [8] [9]
Viral Infections Eczema herpeticum [10], herpes simplex virus [11], and Molluscum contagiosum [12].
Fungal Infections Tinea [11]
Psychological Attention-deficit/Hyperactivity Disorder (ADHD) and speech disorders. [13] [14]


Prognosis

References

  1. ↑ 1.0 1.1 Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1016/j.jaci.2017.09.044 Check |pmid= value (help).
  2. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.4168/aair.2011.3.2.67 Check |pmid= value (help).
  3. ↑ 3.0 3.1 Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1016/S0140-6736(81)92459-4 Check |pmid= value (help).
  4. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1111/j.1600-0536.1990.tb01595.x Check |pmid= value (help).
  5. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1016/j.cyto.2014.11.023. doi: 10.1016/j.cyto.2014.11.023. Check |pmid= value (help).
  6. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.2500/aap.2017.38.4005. doi: 10.2500/aap.2017.38.4005. Check |pmid= value (help).
  7. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1111/j.1365-2133.2008.08905.x. doi: 10.1111/j.1365-2133.2008.08905.x. Check |pmid= value (help).
  8. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1111/j.1365-2133.2010.09679.x. doi: 10.1111/j.1365-2133.2010.09679.x. Check |pmid= value (help).
  9. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1007/s12016-016-8548-5. doi: 10.1007/s12016-016-8548-5. Check |pmid= value (help).
  10. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1038/sj.jid.5700657. doi: 10.1038/sj.jid.5700657. Check |pmid= value (help).
  11. ↑ 11.0 11.1 Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.3390/jcm4050884. doi: 10.3390/jcm4050884. Check |pmid= value (help).
  12. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID http://dx.doi.org/10.1016/j.cpha.2016.06.004. Check |pmid= value (help).
  13. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1111/bjd.14697. doi: 10.1111/bjd.14697. Check |pmid= value (help).
  14. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1016/j.jpeds.2015.09.066. doi: 10.1016/j.jpeds.2015.09.066. Check |pmid= value (help).
  15. ↑ Meding B, Wrangsjö K, Järvholm B (2005). "Fifteen-year follow-up of hand eczema: persistence and consequences". Br J Dermatol. 152 (5): 975–80. doi:10.1111/j.1365-2133.2005.06494.x. PMID 15888155.
  16. ↑ Olesen CM, Agner T, Ebbehøj NE, Carøe TK (2019). "Factors influencing prognosis for occupational hand eczema: new trends". Br J Dermatol. 181 (6): 1280–1286. doi:10.1111/bjd.17870. PMID 30851194.
Retrieved from "https://www.wikidoc.org/index.php?title=Eczema_natural_history,_complications_and_prognosis&oldid=1725394"